According to Nova one advisor, the global Cell Culture market size was estimated at USD 21.05 billion in 2021 and is expected to surpass around USD 60.27 billion by 2030 and poised to grow at a compound annual growth rate (CAGR) of 11.9% during the forecast period 2022 to 2030.
According to Nova one advisor, the global Cell Culture market size was estimated at USD 21.05 billion in 2021 and is expected to surpass around USD 60.27 billion by 2030 and poised to grow at a compound annual growth rate (CAGR) of 11.9% during the forecast period 2022 to 2030.
Get the Sample Copy of Report@ https://www.novaoneadvisor.com/report/sample/6787
Key Takeaways:
- By Application, the U.K. Cell Culture market was valued at USD 1.4 Billion in 2021 and expected to witness growth at a CAGR of 14.9% from 2022 to 2030.
- By consumable, the media segment accounted for the largest revenue share of over 50.0% in 2021 due to the availability of a variety of serum- and animal component-free and customized media alternatives, which has increased the market penetration for media products
- Based on product, culture systems held the largest revenue share of over 25.0% in 2021. This can be attributed to the technological advancements in automated systems for research & development applications
- The biopharmaceuticals application segment dominated the market in 2021 with a revenue share of over 25.0% due to the involvement of mammalian lines, such as the Chinese hamster ovary, in the manufacturing of biopharmaceuticals and the rising demand for non-conventional drugs
- North America held the largest revenue share in 2021 due to high research and development investments, presence of a well-established scientific infrastructure, significant demand for animal component-free media, and other factors
- The Asia Pacific region is estimated to grow at the fastest rate over the forecast period due to the growing healthcare expenditure, rising awareness regarding regenerative therapies, and a large potential for clinical research applications
This can be attributed to the increase in biopharmaceutical production, advancements in vaccine research and development, and increasing focus on genetic engineering applications that rely heavily on cell culture techniques.
Innovations in cell culture workflow automation, such as the commercial development of integrated robotic liquid handling systems, are expected to significantly boost the capabilities of current cell culture technologies. For instance, culturing processes are expected to witness improvements in capacity handling and efficiency, and reproducibility in operations. Similarly, automation in cell line development technologies is gaining traction with the launch of new platforms. For instance, in October 2021, CYTENA launched C.STATION, a fully automated cell line development platform, for enhancing antibody and gene therapy production. Such product launches are likely to increase the market penetration of cell culture offerings.
Cell culture models play a pivotal role in the development of novel therapeutics for diseases such as diabetes, cancer, and Parkinson’s diseases. With the increasing emphasis on research and development activities exploring therapeutic candidates for such diseases, the demand for customized media for use in preclinical research is expected to drive the market. Furthermore, demand for serum-free media is likely to witness significant growth due to increasing quality constraints in biopharmaceuticals and the requirement for highly consistent and standardized culturing conditions.
The COVID-19 pandemic has boosted the demand for cell culture products due to the significant role played by culturing technologies in the discovery of novel diagnostic and therapeutic options for the disease. For instance, research applications such as high-throughput COVID-19 drug screening for the identification of potential drug candidates or investigations aimed at understanding the mechanism of viral entry into the host cells are expected to positively affect the market growth. Furthermore, culturing techniques offer essential tools for the production of viral particles for vaccine development, thereby broadening the growth prospects in this domain.
Report Scope of the Cell Culture Market
| Report Coverage | Details |
| Market Size | US$ 60.27 Billion by 2030 |
| Growth Rate | CAGR of 11.9% from 2022 to 2030 |
| Largest Market | North America |
| Fastest Growing Market | Asia Pacific |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | Consumable, product, application and Region, |
Immediate Delivery Available | Buy this Premium Research Report@ https://www.novaoneadvisor.com/report/checkout/6787
Consumable Insights
Media held the largest revenue share of over 50.0% in 2021 due to high demand for media products for research and development applications. The availability of a variety of serum- and animal component-free and customized media alternatives has increased the market penetration for media products. Furthermore, specialized media for stem cell applications is being increasingly commercialized, which is expected to boost the growth of the segment. For instance, companies such as Thermo Fisher Scientific, Inc. and Sartorius AG offer media products optimized for stem cell culturing.
The reagents segment is expected to register the fastest CAGR over the forecast period due to the increasing significance of albumin for carrying serum-derived substances that support mammalian cultures. Other reagents such as antibiotics and amino acids are being increasingly used for applications in primary cultures to ensure the maintenance of a sterile and nutrient-rich environment in the culture systems. These factors are expected to significantly boost the segment growth.
Product Insights
Culture systems dominated the market and accounted for over 25.0% share in 2021. The segment is also expected to register the fastest CAGR over the forecast period due to the development of technologically advanced and automated culturing systems. For instance, in March 2022, CELLINK launched its BIO CELLX bio-dispensing platform for the automation of 3D cell-based assays for drug discovery and cancer research. Such product launches are likely to broaden the growth prospects for the segment.
Centrifuges are anticipated to witness significant growth over the forecast period as benchtop centrifuges are gaining efficiency in operations and they offer reliability for everyday laboratory use. Furthermore, bioprocessing centrifuges are commercially available for high-quality, rapid, and high-yield cell separation, which can increase the adoption of the technique. With the growing need for centrifuges for the production of gene therapies, antibodies, and vaccines, the demand for the product is expected to grow in the near future.
Application Insights
The biopharmaceuticals segment held the largest revenue share of over 25.0% in 2021. Due to the involvement of mammalian cell lines, such as the Chinese hamster ovary, in the manufacturing of biopharmaceuticals and the rising demand for non-conventional drugs, biopharmaceutical applications of cell culture techniques are expected to witness growth. In addition, the development of several grafting techniques and personalized treatment options in recent years has expanded the growth prospects in the biopharmaceutical domain.
Vaccine production is projected to expand at a lucrative CAGR over the forecast period due to the increasing importance of culturing techniques for the production of viral vaccines grown using Madin-Darby Canine Kidney, pMK, Vero, or human lines such as HEK 293 and MRC 5. With accelerated vaccine approval processes and large investments in vaccine manufacturing fueled by the COVID-19 pandemic, vaccine production applications of the technique are likely to positively affect the industry growth.
Regional Insights
North America held the largest revenue share of over 40.0% in 2021 due to high research and development investments, the presence of a well-established scientific infrastructure, significant demand for animal component-free media, and other factors.
Furthermore, ongoing research and expansion of the biopharmaceutical sector in the U.S. are expected to boost the industry growth in the region. The presence of key players such as Bio-Rad Laboratories, Inc.; Thermo Fisher Scientific, Inc.; and Becton, Dickinson and Company can significantly drive the market.
The Asia Pacific region is projected to expand at the fastest CAGR over the forecast period due to the growing healthcare expenditure, rising awareness regarding cell and gene therapies, and a large potential for clinical research applications. Furthermore, rapid adoption of scientific technologies and emerging therapeutics, such as regenerative medicines and cancer immunotherapies, is likely to strengthen the industry growth in the near future.
Some of the prominent players in the Cell Culture Market include:
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific, Inc.
- Becton, Dickinson and Company
- Merck KGaA
- Sartorius AG
- VWR International, LLC
- Eppendorf SE
- PromoCell GmbH
- Bio-Techne Corporation
- BioSpherix, Ltd.
Segments Covered in the Report
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Nova one advisor, Inc. has segmented the global Cell Culture market
- Consumable
- Media
- Minimum Essential Media (MEM)
- RPMI 1640 Media
- DMEM/F-12 Media
- F-10 Serum Free Media
- BME Media
- Insect Media
- Other Media
- Sera
- Fetal Bovine Serum
- Other AnimalSerum
- Reagents
- Albumin
- Other
- Media
- Product
- Culture Systems
- Incubators
- Centrifuges
- Cryostorage Equipment
- Biosafety Equipment
- Pipetting Instruments
- Application
- Biopharmaceuticals
- Tissue Culture & Engineering
- Vaccine Production
- Drug Development
- Gene Therapy
- Toxicity Testing
- Cancer Research
- Others
By Geography
North America
- U.S.
- Canada
Europe
- Germany
- France
- United Kingdom
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Southeast Asia
- Rest of Asia Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC
- North Africa
- South Africa
- Rest of Middle East & Africa
For Purchase Inquiry@ https://www.novaoneadvisor.com/report/checkout/6787
About Us
Nova One Advisor is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Nova One Advisor has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.
You can place an order or ask any questions, please feel free to sales@novaoneadvisor.com| +1 9197 992 333